Metropolis Healthcare Limited has informed the Exchange regarding Outcome of Postal Ballot. Further, the company has submitted the Exchange a copy of Srutinizers report
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 1.4 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Metropolis Healthcare has completed a Postal Ballot process, and shareholders have approved three resolutions with overwhelming majority. Mr. Surendran Chemmenkotil (DIN: 10818890) has been appointed as the new Managing Director of the company, receiving 96.13% votes in favour (approximately 4.52 crore shares out of 4.70 crore polled). Additionally, Ms. Purvi Sheth and Mr. Rehan Khan have been appointed as Non-Executive Independent Directors, with 99.57% and 99.99% approval respectively. The voting was conducted via remote e-voting between May 16 and June 14, 2025, with about 90.74% of total shares participating. Promoters voted 100% in favour of all resolutions, while public institutions showed strong support (around 91.59% to 100% in favour across resolutions).
The appointment of a new Managing Director signals a leadership transition at Metropolis Healthcare, which could shape the company's strategic direction going forward. The strong shareholder approval (over 96%) reflects broad confidence in the new leadership and governance changes. Investors will likely monitor the new MD's strategy and execution closely.